Becton, Dickinson and Company BDX, popularly known as BD, recently unveiled the BD FACSDiscover A8 Cell Analyzer. This advanced platform integrates breakthrough spectral flow cytometry with real-time ...
Featured in the journal Science and unveiled at last year’s International Society for Advancement of Cytometry CYTO conference, BD‘s first-of-its-kind cell-sorting technology has now launched ...
BD demonstrated how its portfolio supports the evolving needs of pharmaceutical and biotechnology companies developing biologics – GLP-1 therapies, vaccines, and acute care medicines – as the industry ...
FRANKLIN LAKES, N.J., July 23, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announces the first pharma-sponsored combination ...
BD Launches New Cell Analyzer Configurations to Bring Cutting-Edge Capabilities to Labs of All Sizes
FRANKLIN LAKES, N.J., Dec. 3, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the global commercial release of new ...
Becton, Dickinson and Co. plans to invest more than $35 million to expand a prefilled flush syringe manufacturing facility in Nebraska to better meet growing demand from U.S. hospitals and health care ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results